JD Capital invests 80 million RMB in Guangxi Tianyuan Biochemical, enhancing its market position in the Chinese pesticide sector.

Information on the Target

The target of this investment is Guangxi Tianyuan Biochemical, one of the largest pesticide manufacturing companies in Southwest China. The company has recently attracted significant attention due to its strategic focus on the rice pesticide market, where it has established itself as a leading player. With an estimated sales revenue of 800 million RMB in 2008, Tianyuan’s growth trajectory seems promising as it continues to expand its market share, particularly in the context of a transforming agricultural industry in China.

Tianyuan Biochemical’s significant market presence is set against a backdrop of industry consolidation, especially after stringent regulatory changes that have pushed several smaller players out of the market. As a result, the company is positioned to capitalize on the growing demand for high-quality pesticide products, making it an appealing target for investment.

Industry Overview in China

The agricultural investment landscape in China has been evolving rapidly, especially following the global food crisis. The total investment in agriculture has risen remarkably from 640,000 USD in 2002 to

View Source

Similar Deals

Jiuding Capital Huizhou Zhongxun Chemical Engineering Co., Ltd.

2023

Growth Equity & Expansion Capital Pesticides China
耀途资本、韩国SV基金 赣州赛可韦尔科技有限公司

2025

Series A Nonferrous Metal Processing China
SPE PEF III, Proparco, Amethis MENA Fund II Delta Holdings B.V.

2025

Growth Equity & Expansion Capital Specialty Chemicals (NEC) Egypt
智元机器人 上纬新材

2025

Other Private Equity Specialty Mining & Metals (NEC) China
Advantage Capital United Metallurgical Equipment Companies of Cincinnati (UMECC)

2025

Growth Equity & Expansion Capital Iron, Steel Mills & Foundries United States of America
山東金飛高温材料有限公司 溜博高見澤混凝土有限公司

2025

Joint Venture Cement & Concrete Manufacturing China

九鼎投资

invested in

广西田园生化

in 2009

in a Growth Equity & Expansion Capital deal

Disclosed details

Transaction Size: $1M

Revenue: $1M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert